Wealth Enhancement Advisory Services’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,017
Closed -$75.4K – 4481
2026
Q2
$75.4K Buy
+10,017
New +$83.9K ﹤0.01% 3854

Other funds holding UPB

Wealth Enhancement Advisory Services's UPB Position: Q3 2026 in Review

Wealth Enhancement Advisory Services sold out of Upstream Bio (UPB) in Q3 2026, closing a stake of 10,017 shares — an estimated $75.4K sold.

Wealth Enhancement Advisory Services first reported a position in UPB in Q2 2026 and held it in 1 quarter. The position peaked at $75.4K in Q2 2026. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Wealth Enhancement Advisory Services reported no remaining Upstream Bio position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 10,017 Upstream Bio shares in Q3 2026, an estimated $75.4K.
  • Wealth Enhancement Advisory Services first reported a position in Upstream Bio in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Advisory Services's Upstream Bio position peaked at $75.4K in Q2 2026.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.